Open access journal
Users online:
191
Home
|
About
|
Feedback
|
Reader Login
Current Issue
Back Issues
Editorial Board
Authors and Reviewers
How to Subscribe
Advertise with us
Contact Us
Analgesic Prescription
»
Site Statistics
»
Addresses
»
Search
»
My Preferences
»
Online Submission
»
PG Fellowship in Palliative Medicine
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2020| April-June | Volume 26 | Issue 2
Online since
June 6, 2020
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
REPUBLICATION: SPECIAL ARTICLE (GUIDELINES)
Indian society for study of pain, cancer pain special interest group guidelines, for the diagnosis and assessment of cancer pain
Aparna Chatterjee, Raghu S Thota, Raghavendra Ramanjulu, Arif Ahmed, Dipasri Bhattacharya, Naveen Salins, Parmanand Jain, Sushma Bhatnagar
April-June 2020, 26(2):164-172
DOI
:10.4103/0973-1075.285691
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group (SIG) guidelines, for the diagnosis and assessment of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide the patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs of patient population and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care (IAPC) members. We recommend that a comprehensive pain assessment of all the patients should be conducted before initiating treatment. The patients should be educated about all the available pain control interventions. For assessing cancer pain, unidimensional tools such as Numeric Rating Scale, Visual Analog Scale, and Visual Rating Scale should always be used routinely. Patients with cancer pain should routinely be screened for distress and other psychological disorders, using the Patient Health Questionnaire-9. The most reliable assessment of pain is patients' self-reporting.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,481
82
-
NARRATIVE REVIEW
Methadone in Cancer Pain
S Ramkiran, Raghu S Thota
April-June 2020, 26(2):215-220
DOI
:10.4103/0973-1075.285690
Methadone has been an unique, versatile, cost effective, synthetic opioid utilized in nociceptive as well as neuropathic pain. Pain and palliative care physicians started accepting methadone in treatment of complex pain associated with advanced cancer and neuropathic pain syndromes in which conventional opioids were no longer effective. The challenge is in accepting methadone as a main stream first line opioid , from being considered as a second line replacement/substitution drug all these years. Methadone has a significant role as opioid rotation in refractory cancer pain, especially when started early leading to successful conversion. Advantages of methadone in paediatric patients with advanced cancer were its safety and efficacy as a first-choice opioid, availability as a liquid formulation and its infrequent dose requirements. Methadone is neither recommended nor justified to be used as an anti-cancer drug and its role as an anti-cancer agent is a misconception. Many guidelines were proposed after 2008 to address methadone safety. Most of them emphasized on prevention of cardiac arrhythmia and association of methadone with QTc prolongation rather than address the real issue. Methadone has been established to be safe when used in opioid naiïve patients with careful titration instituted in an ambulatory setting and has equal success in opioid rotation in outpatient setup. Methadone prescription should be carried out by experienced pain and palliative care providers with careful dose titration and clinical monitoring.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,366
82
-
EDITORIALS
The Indian society for study of pain, cancer pain special interest group guidelines on cancer pain management in adults
Parmanand Jain, Raghu S Thota
April-June 2020, 26(2):157-158
DOI
:10.4103/0973-1075.285685
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,198
72
-
REPUBLICATION: SPECIAL ARTICLE (GUIDELINES)
Indian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part II)
Raghu S Thota, Raghavendra Ramanjulu, Arif Ahmed, Parmanand Jain, Naveen Salins, Sushma Bhatnagar, Aparna Chatterjee, Dipasri Bhattacharya
April-June 2020, 26(2):180-190
DOI
:10.4103/0973-1075.285693
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group (SIG) guidelines on pharmacological management of cancer pain in adults provide a structured, stepwise approach, which will help to improve the management of cancer pain and to provide the patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire, based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by e-mail to all the ISSP and Indian Association of Palliative Care members. We recommend that analgesics for cancer pain management should follow the World Health Organization 3-step analgesic ladder appropriate for the severity of pain. The use of paracetamol and nonsteroidal anti-inflammatory drugs alone or in combination with opioids for mild-to-moderate pain should be used. For mild-to-moderate pain, weak opioids such as tramadol, tapentadol, and codeine can be given in combination with nonopioid analgesics. We recommend morphine as the opioid of the first choice for moderate-to-severe cancer pain. Sustained-release formulations can be started 12 hourly, once the effective 24 h dose with immediate-release morphine is established. Opioid switch or rotation should be considered if there is inadequate analgesia or intolerable side effects. For opioid-induced respiratory depression, μ receptor antagonists (e.g. naloxone) must be used promptly. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain, and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus, it is not recommended.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,127
73
-
Indian society for study of pain, cancer pain special interest group guidelines on complementary therapies for cancer pain
Arif Ahmed, Raghu S Thota, Sushma Bhatnagar, Parmanand Jain, Raghavendra Ramanjulu, Naveen Salins, Aparna Chatterjee, Dipasri Bhattacharya
April-June 2020, 26(2):198-202
DOI
:10.4103/0973-1075.285695
The Indian Society for Study of Pain (ISSP), cancer pain Special Interest Group (SIG) guidelines on complementary therapies for cancer pain in adults provides a structured, stepwise approach which will help to improve the management of cancer pain and to provide the patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub drafts addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by e-mail to all the ISSP and Indian Association of Palliative Care members. We recommend that psychological interventions, including psychoeducation, are useful and should be considered in patients with cancer pain and psychological distress. Furthermore, physical and complementary treatment can be used as an adjunctive therapy for patients with cancer pain.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,110
71
-
Indian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part I)
Raghavendra Ramanjulu, Raghu S Thota, Arif Ahmed, Parmanand Jain, Naveen Salins, Sushma Bhatnagar, Aparna Chatterjee, Dipasri Bhattacharya
April-June 2020, 26(2):173-179
DOI
:10.4103/0973-1075.285692
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain in adults provides a structured, step-wise approach which will help to improve the management of cancer pain and to provide the patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub drafts addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website, and circulated by E-mail to all the ISSP and Indian Association of Palliative Care (IAPC) members. We recommend that analgesics for cancer pain management should follow the World Health Organization three-step analgesic ladder appropriate for the severity of pain. The use of paracetamol and nonsteroidal anti-inflammatory drugs alone or in combination with opioids for mild-to-moderate pain should be used. For mild-to-moderate pain, weak opioids such as tramadol, tapentadol, and codeine can be given in combination with nonopioid analgesics. We recommend morphine as the opioid of first choice for moderate-to-severe cancer pain.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,018
79
-
Indian society for study of pain, cancer pain special interest group guidelines on interventional management for cancer pain
Arif Ahmed, Raghu S Thota, Aparna Chatterjee, Parmanand Jain, Raghavendra Ramanjulu, Sushma Bhatnagar, Naveen Salins, Dipasri Bhattacharya
April-June 2020, 26(2):203-209
DOI
:10.4103/0973-1075.285696
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group guidelines on interventional management for cancer pain in adults provide a structured, stepwise approach which will help to improve the management of cancer pain and to provide the patients with minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking was made available on the ISSP website and circulated by e-mail to all the ISSP and Indian Association of Palliative Care members. We recommend using interventional management when conventional therapy fails to offer adequate benefits or causes undesirable side effects. Vertebroplasty should be offered to patients with uncontrolled bone pain when expertise is available.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
967
70
-
Indian society for study of pain, cancer pain special interest group guidelines on palliative care aspects in cancer pain management
Naveen Salins, Raghu S Thota, Sushma Bhatnagar, Raghavendra Ramanjulu, Arif Ahmed, Parmanand Jain, Aparna Chatterjee, Dipasri Bhattacharya
April-June 2020, 26(2):210-214
DOI
:10.4103/0973-1075.285687
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group guidelines on palliative care aspects in cancer pain in adults provide a structured, stepwise approach which will help to improve the management of cancer pain and to provide the patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care (IAPC) members. In a cancer care setting, approaches toward managing pain vary between ambulatory setting, home care setting, acute inpatient setting, and end-of-life care in hospice setting. We aim to expound the cancer pain management approaches in these settings. In an ambulatory palliative care setting, the WHO analgesic step ladder is used for cancer pain management. The patients with cancer pain require admission for acute inpatient palliative care unit for poorly controlled pain in ambulatory and home care settings, rapid opioid titration, titration of difficult drugs such as methadone, acute pain crisis, pain neuromodulation, and pain interventions. In a palliative home care setting, the cancer pain is usually assessed and managed by nurses and primary physicians with a limited input from the specialist physicians. In patients with cancer at the end of life, the pain should be assessed at least once a day. Moreover, physicians should be trained in assessing patients with pain who are unable to verbalize or have cognitive impairment.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
855
74
-
Indian society for study of pain, cancer pain special interest group guidelines on pharmacological management of cancer pain (Part III)
Raghavendra Ramanjulu, Raghu S Thota, Arif Ahmed, Parmanand Jain, Sushma Bhatnagar, Naveen Salins, Aparna Chatterjee, Dipasri Bhattacharya
April-June 2020, 26(2):191-197
DOI
:10.4103/0973-1075.285694
The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care members. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on the use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus it is not recommended.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
655
62
-
IAPCON 2020 ABSTRACTS
Poster Presentations
April-June 2020, 26(2):237-268
DOI
:10.4103/0973-1075.285689
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
506
66
-
Oral Presentations
April-June 2020, 26(2):221-236
DOI
:10.4103/0973-1075.285688
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
486
71
-
EDITORIALS
IAPCON 2020: Conference Proceedings
Sanghamitra Bora, Kalpajit Dutta
April-June 2020, 26(2):159-163
DOI
:10.4103/0973-1075.285686
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
485
58
-
IAPCON 2020: Conference Editorial
Sanghamitra Bora
April-June 2020, 26(2):155-156
DOI
:10.4103/0973-1075.285684
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
458
66
-
Site Map
|
Home
|
Contact Us
|
Feedback
|
Copyright and Disclaimer
Online since 1
st
October '05
Published by Wolters Kluwer -
Medknow